Haeun Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Haeun Lee has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- In O. Sun
Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Republic of Korea
6 shared publications - A Young Cho
Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Republic of Korea
4 shared publications - Byung Ha Chung
Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Republic of Korea
4 shared publications - Hanbi Lee
Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Republic of Korea
4 shared publications - Ju Hwan Oh
Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Republic of Korea
4 shared publications - Chul Woo Yang
Division of Nephrology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
Association between the number of pregnancies and chronic kidney disease in Korean women: a population-based cross-sectional study from the Korean Genome and Epidemiology Study-Health Examinee (KoGES-HEXA) cohort
- 18 September 2026
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
Open AccessAssociation between the number of pregnancies and chronic kidney disease in Korean women: a population-based cross-sectional study from the Korean Genome and Epidemiology Study-Health Examinee (KoGES-HEXA) cohort
- Open Access
- 21 July 2026
- Published by Kosin University College of Medicine in Kosin Medical Journal
Acute necrotizing esophagitis associated with extremely severe metabolic acidosis from alcoholic ketoacidosis: a case report
Acute necrotizing esophagitis associated with extremely severe metabolic acidosis from alcoholic ketoacidosis: a case report
- 21 July 2026
- Published by Kosin University College of Medicine in Kosin Medical Journal
Open AccessAcute necrotizing esophagitis associated with extremely severe metabolic acidosis from alcoholic ketoacidosis: a case report
Acute necrotizing esophagitis associated with extremely severe metabolic acidosis from alcoholic ketoacidosis: a case report
- Open Access
- 12 December 2025
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
Effectiveness and safety of tocilizumab treatment for chronic active antibody-mediated rejection in kidney transplant recipients
Background: Chronic active antibody-mediated rejection (cABMR) is a leading cause of allograft failure in kidney transplantation (KT) recipients. However, no effective treatment has been established. This study investigated the effectiveness and safety of tocilizumab (TCZ), an anti-interleukin-6 receptor antibody, in delaying cABMR progression in KT recipients. Methods: We included 18 KT recipients with cABMR treated with TCZ (8 mg/kg/mo for 6 months). The primary outcome was allograft survival. Secondary outcomes included changes in the estimated glomerular filtration rate (eGFR), proteinuria, mean fluorescence intensity (MFI) of anti-human leukocyte antigen (HLA) antibodies, and adverse events (AEs). Results: During a mean follow-up of 18.2 months, allograft failure occurred in eight patients (44.4%). Baseline eGFR was the only significant predictor of allograft failure (hazard ratio, 0.854; 95% confidence interval, 0.791-0.959). In most patients, TCZ reduced the MFI of anti-HLA antibodies. The decline in eGFR was attenuated after TCZ treatment (ΔeGFR from-11.5 ± 10.7 to-2.9 ± 6.6 mL/min/1.73 m 2 , p = 0.03). Proteinuria decreased from 1.9 ± 2.2 g/g to 1.3 ± 1.4 g/g, although the change was not statistically significant. AEs included infections (n = 5), hypogammaglobulinemia (n = 6), and leukopenia (n = 2), with TCZ discontinued in one case of severe leukopenia. The results of the subgroup analysis suggested favorable outcomes in the preserved eGFR group (≥25.5 mL/ min/1.73 m 2) compared with the reduced eGFR group (<25.5 mL/min/1.73 m 2). Conclusion: TCZ should be selectively used in patients with preserved allograft function, considering the limited evidence, potential risks, and substantial costs.
- 12 December 2025
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
Open AccessEffectiveness and safety of tocilizumab treatment for chronic active antibody-mediated rejection in kidney transplant recipients
Background: Chronic active antibody-mediated rejection (cABMR) is a leading cause of allograft failure in kidney transplantation (KT) recipients. However, no effective treatment has been established. This study investigated the effectiveness and safety of tocilizumab (TCZ), an anti-interleukin-6 receptor antibody, in delaying cABMR progression in KT recipients. Methods: We included 18 KT recipients with cABMR treated with TCZ (8 mg/kg/mo for 6 months). The primary outcome was allograft survival. Secondary outcomes included changes in the estimated glomerular filtration rate (eGFR), proteinuria, mean fluorescence intensity (MFI) of anti-human leukocyte antigen (HLA) antibodies, and adverse events (AEs). Results: During a mean follow-up of 18.2 months, allograft failure occurred in eight patients (44.4%). Baseline eGFR was the only significant predictor of allograft failure (hazard ratio, 0.854; 95% confidence interval, 0.791-0.959). In most patients, TCZ reduced the MFI of anti-HLA antibodies. The decline in eGFR was attenuated after TCZ treatment (ΔeGFR from-11.5 ± 10.7 to-2.9 ± 6.6 mL/min/1.73 m 2 , p = 0.03). Proteinuria decreased from 1.9 ± 2.2 g/g to 1.3 ± 1.4 g/g, although the change was not statistically significant. AEs included infections (n = 5), hypogammaglobulinemia (n = 6), and leukopenia (n = 2), with TCZ discontinued in one case of severe leukopenia. The results of the subgroup analysis suggested favorable outcomes in the preserved eGFR group (≥25.5 mL/ min/1.73 m 2) compared with the reduced eGFR group (<25.5 mL/min/1.73 m 2). Conclusion: TCZ should be selectively used in patients with preserved allograft function, considering the limited evidence, potential risks, and substantial costs.
- Open Access
- 30 November 2024
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 43 (6) , 797-806
Circulating microRNAs as markers for scrub typhus-associated acute kidney injury
Background: Circulating microRNAs (miRNAs) are potential biomarkers for various kidney diseases. In this study, we aimed to identify a circulating miRNA signature for detecting acute kidney injury (AKI) in scrub typhus. Methods: We prospectively enrolled 40 patients with scrub typhus (20 with AKI, AKI group; 20 without AKI, non-AKI group) and 20 healthy volunteers (the HV group). Thereafter, we performed microarray analysis to assess the serum miRNA profiles of all the participants. Then, to identify miRNAs predictive of scrub typhus-associated AKI, we compared miRNA profiles among these three groups. Results: The proportions of miRNAs, small nucleolar RNAs, and small Cajal body-specific ribonucleoproteins were higher in patients with scrub typhus than in the HVs. Further, relative to the HVs, we identified 120 upregulated and 449 downregulated miRNAs in the non-AKI group and 101 upregulated and 468 downregulated miRNAs in the AKI group. We also identified 11 and 110 upregulated and downregulated miRNAs, respectively, in the AKI group relative to the non-AKI group, and among these miRNAs, we noted 14 miRNAs whose levels were significantly upregulated or downregulated in the AKI group relative to their levels in the HV and non-AKI groups. Biological pathway analysis of these 14 miRNAs indicated their potential involvement in various pathways associated with tumor necrosis factor alpha. Conclusion: We identified miRNAs associated with AKI in patients with scrub typhus that have predictive potential for AKI. Thus, they can be used as surrogate markers for the detection of scrub typhus-associated AKI.
- 30 November 2024
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 43 (6) , 797-806
Open AccessCirculating microRNAs as markers for scrub typhus-associated acute kidney injury
Background: Circulating microRNAs (miRNAs) are potential biomarkers for various kidney diseases. In this study, we aimed to identify a circulating miRNA signature for detecting acute kidney injury (AKI) in scrub typhus. Methods: We prospectively enrolled 40 patients with scrub typhus (20 with AKI, AKI group; 20 without AKI, non-AKI group) and 20 healthy volunteers (the HV group). Thereafter, we performed microarray analysis to assess the serum miRNA profiles of all the participants. Then, to identify miRNAs predictive of scrub typhus-associated AKI, we compared miRNA profiles among these three groups. Results: The proportions of miRNAs, small nucleolar RNAs, and small Cajal body-specific ribonucleoproteins were higher in patients with scrub typhus than in the HVs. Further, relative to the HVs, we identified 120 upregulated and 449 downregulated miRNAs in the non-AKI group and 101 upregulated and 468 downregulated miRNAs in the AKI group. We also identified 11 and 110 upregulated and downregulated miRNAs, respectively, in the AKI group relative to the non-AKI group, and among these miRNAs, we noted 14 miRNAs whose levels were significantly upregulated or downregulated in the AKI group relative to their levels in the HV and non-AKI groups. Biological pathway analysis of these 14 miRNAs indicated their potential involvement in various pathways associated with tumor necrosis factor alpha. Conclusion: We identified miRNAs associated with AKI in patients with scrub typhus that have predictive potential for AKI. Thus, they can be used as surrogate markers for the detection of scrub typhus-associated AKI.
- Open Access
- 31 March 2024
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 43 (2) , 250-252
Renal infarction caused by spontaneous renal artery dissection after playing golf
A 59-year-old man presented to our clinic with severe left flank pain after vigorous golfing. The patient exhibited tenderness at the left costovertebral angle. He had a history of hypertension and diabetes, both of which were well-controlled with medication. No recent trauma or endovascular procedures were reported. Laboratory tests showed elevated C-reactive protein (5.3 mg/dL) levels, but complete blood cell counts, creatinine levels, and urinalysis were unremarkable. A serum cholesterol test showed total cholesterol levels of 129 mg/dL, low-density lipoprotein cholesterol levels of 58 mg/dL, and triglyceride levels of 141 mg/dL. Computed tomography (CT) revealed a left renal infarction and the presence of dual left renal arteries with narrowing and irregularity in the left upper renal artery with an intraluminal hematoma, suggesting renal artery dissection. A 1.5-cm aneurysmal dilatation was also noted (Fig. 1A). CT angiography excluded other underlying arteriopathies, such as atherosclerosis, fibromuscular dysplasia, or connective tissue disorders (Fig. 2). Electrocardiogram and 24-hour Holter monitoring revealed normal sinus rhythm without arrhythmias. Echocardiography revealed the absence of intracardiac masses or thrombi. Laboratory tests revealed no abnormalities in coagulation. We suspected that spontaneous renal artery dissection (SRAD) caused the acute infarction in the left kidney.
- 31 March 2024
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 43 (2) , 250-252
Open AccessRenal infarction caused by spontaneous renal artery dissection after playing golf
A 59-year-old man presented to our clinic with severe left flank pain after vigorous golfing. The patient exhibited tenderness at the left costovertebral angle. He had a history of hypertension and diabetes, both of which were well-controlled with medication. No recent trauma or endovascular procedures were reported. Laboratory tests showed elevated C-reactive protein (5.3 mg/dL) levels, but complete blood cell counts, creatinine levels, and urinalysis were unremarkable. A serum cholesterol test showed total cholesterol levels of 129 mg/dL, low-density lipoprotein cholesterol levels of 58 mg/dL, and triglyceride levels of 141 mg/dL. Computed tomography (CT) revealed a left renal infarction and the presence of dual left renal arteries with narrowing and irregularity in the left upper renal artery with an intraluminal hematoma, suggesting renal artery dissection. A 1.5-cm aneurysmal dilatation was also noted (Fig. 1A). CT angiography excluded other underlying arteriopathies, such as atherosclerosis, fibromuscular dysplasia, or connective tissue disorders (Fig. 2). Electrocardiogram and 24-hour Holter monitoring revealed normal sinus rhythm without arrhythmias. Echocardiography revealed the absence of intracardiac masses or thrombi. Laboratory tests revealed no abnormalities in coagulation. We suspected that spontaneous renal artery dissection (SRAD) caused the acute infarction in the left kidney.
- Open Access
- 31 January 2024
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 43 (1) , 125-129
Successful diagnosis and treatment of recurrent atypical hemolytic uremic syndrome posttransplantation caused by the heterozygous deletion of CFH in a patient with end-stage kidney disease of uncertain etiology
Atypical hemolytic uremic syndrome (aHUS) is a rare disease caused by the dysregulation of the alternative pathway of the complement system, leading to microvascular damage. It is a type of thrombotic microangiopathy (TMA) characterized by non-immune hemolytic anemia, thrombocytopenia, and renal impairment. Half of the patients with aHUS develop end-stage kidney disease (ESKD) [1]. Genetic testing is crucial for the diagnosis of aHUS, as variants in complement regulatory protein gene significantly Successful diagnosis and treatment of recurrent atypical hemolytic uremic syndrome posttransplantation caused
- 31 January 2024
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 43 (1) , 125-129
Open AccessSuccessful diagnosis and treatment of recurrent atypical hemolytic uremic syndrome posttransplantation caused by the heterozygous deletion of CFH in a patient with end-stage kidney disease of uncertain etiology
Atypical hemolytic uremic syndrome (aHUS) is a rare disease caused by the dysregulation of the alternative pathway of the complement system, leading to microvascular damage. It is a type of thrombotic microangiopathy (TMA) characterized by non-immune hemolytic anemia, thrombocytopenia, and renal impairment. Half of the patients with aHUS develop end-stage kidney disease (ESKD) [1]. Genetic testing is crucial for the diagnosis of aHUS, as variants in complement regulatory protein gene significantly Successful diagnosis and treatment of recurrent atypical hemolytic uremic syndrome posttransplantation caused
- Open Access
- 31 July 2023
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 42 (4) , 534-537
Renal hypouricemia as the cause of exercise-induced acute kidney injury
- 31 July 2023
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 42 (4) , 534-537
Open AccessRenal hypouricemia as the cause of exercise-induced acute kidney injury
- Open Access
- 24 February 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 43 (4) , 364-374
Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients
Haeun Lee, M.D., Hanbi Lee, M.D., Sang Hun Eum, M.D., Eun Jeong Ko, M.D., Ph.D., Ji-Won Min, M.D., Ph.D., Eun-Jee Oh, M.D., Ph.D., Chul Woo Yang, M.D., Ph.D., and Byung Ha Chung, M.D., Ph.D.. Ann Lab Med 2023;43:364-74. https://doi.org/10.3343/alm.2023.43.4.364
- 24 February 2023
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 43 (4) , 364-374
Open AccessImpact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients
Haeun Lee, M.D., Hanbi Lee, M.D., Sang Hun Eum, M.D., Eun Jeong Ko, M.D., Ph.D., Ji-Won Min, M.D., Ph.D., Eun-Jee Oh, M.D., Ph.D., Chul Woo Yang, M.D., Ph.D., and Byung Ha Chung, M.D., Ph.D.. Ann Lab Med 2023;43:364-74. https://doi.org/10.3343/alm.2023.43.4.364
- Open Access
- 22 September 2022
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 41 (5) , 635-636
Ureteral stent infection caused by Candida in a renal transplant recipient
- 22 September 2022
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 41 (5) , 635-636
Open AccessUreteral stent infection caused by Candida in a renal transplant recipient